Venu VENU Stock Is It a Strong Investment Pick Venu Sees 225 EPS Miss Wider Than Expected Loss AGMB AgomAb outlines key upcoming clinical trial milestones in its newly released quarterly earnings report OSBC Old Second stock rises 19 percent following Q1 2026 results even as it misses analyst consensus EPS estimates American Tower Corporation AMT Outperforms Broad Market Selloff But Faces Structural Headwinds Ahead of Q1 2026 Earnings Release Entergy ENO Sector Rotation